Viyash Life Sciences

Executive Snapshot

Viyash Lifesciences, a global pharmaceutical leader, faced the dual challenge of rapidly maturing its ESG framework with limited resources while securing a globally auditable GHG baseline and improving its critical EcoVadis standing. Oren implemented a 12-month integrated strategy, combining deep consulting expertise with the efficiency of Oren's AI-powered ESG platform, Oren Sustainability Hub. This approach delivered a two-fold increase in the client’s EcoVadis responsible procurement score and established a verified GHG baseline across all nine operational sites, positioning the company for sustained compliance and long-term decarbonisation planning.

Client Profile

Viyash Life Sciences is a critical player in global healthcare, operating eight manufacturing plants and distributing essential pharmaceutical products across 150+ countries. Their commitment to sustainable operations and governance is central to maintaining stakeholder trust and ensuring market access.

• Industry: Pharmaceutical Manufacturing
• Company: Private
• Number of Employees: 2,500
• Headquarter: Hyderabad, India
• Global Presence: 150+ Countries

The Challenge

Viyash Lifesciences required a comprehensive, resource-efficient approach to meet increasing international ESG demands within a 12-month timeframe. The core challenges were distinct, high-stakes business requirements:

• Materiality Alignment: Defining the most impactful ESG topics for the API and formulation sector to align strategy with stakeholder and regulatory expectations.
• Comprehensive GHG Baseline: Establishing a precise, auditable baseline for Scope 1, 2, and 3 emissions across nine complex operational sites to meet SBTi commitment prerequisites.
• Critical Supply Chain Performance: Elevating the ESG performance of the top 30+ suppliers to mitigate risk and meet increasingly strict procurement standards from global partners.
• EcoVadis Score Improvement: Rapidly enhancing performance across all four themes, specifically addressing the highly weighted Responsible Procurement category.

Oren’s Strategic Solution

Oren deployed a unified solution leveraging both expert consulting and Oren Sustainability Hub to deliver efficiency and audit-readiness.

• Integrated Strategy: We conducted a structured materiality assessment, engaging internal and external stakeholders to prioritise key pharmaceutical sector topics, forming the foundation for all subsequent reporting.
• Precision GHG Accounting: Oren collected and calculated Scope 1, 2, and 3 emissions across all nine locations. For Scope 3, we utilised our AI-powered ESG Platform’s competitive advantage: HSN-based code mapping for spend data. This provides a detailed, item-level classification of goods and services, leading to a significantly more granular and defensible Scope 3 emissions profile than standard high-level spend allocation. This clarity is essential for management decisions on capital and operational expenditures.
• Targeted Supply Chain Engagement: We moved beyond simple data collection using Oren Sustainability Hub. This module enabled direct engagement with the client’s top suppliers, categorising them into performance tiers (red, amber, and green) and implementing targeted action plans to drive measurable improvements in the supply chain’s overall ESG maturity.
• Reporting and Assurance: Oren Sustainability Hub's automated data collection with maker-checker controls and document attachment, culminating in the development of a comprehensive GRI-aligned sustainability report. This structured approach provides the necessary transparency and assurance for external auditors and senior leadership.

Measurable Results

Oren’s focus on data structure and application yielded four key, quantifiable outcomes within the 12-month period:

• EcoVadis Score Achievement: Successfully achieved a two-fold increase in the crucial Responsible Procurement section of the EcoVadis assessment.
• Auditable GHG Baseline: Established a verified Scope 1, 2, and 3 emissions baseline across all 9 locations, fulfilling the prerequisite for future SBTi commitment and decarbonisation planning.
• Supplier Risk Mitigation: Engaged and tracked ESG performance improvements for 30+ critical suppliers via Oren Sustainability Hub, directly reducing supply chain exposure and strengthening procurement standards.
• Global Reporting Compliance: Successful development and publication of a comprehensive sustainability report aligned with Global Reporting Initiative (GRI) standards, enhancing transparency and investor trust.

Conclusion

Through a structured, technology-enabled approach, Oren transformed Viyash Lifesciences’ ESG maturity within just 12 months, strengthening compliance, deepening data integrity, and elevating global stakeholder confidence. By combining precision GHG accounting, targeted supplier engagement, and EcoVadis-focused interventions with the power of Oren Sustainability Hub, the company now operates with an auditable GHG baseline, significantly enhanced procurement maturity, and a scalable ESG framework aligned with global expectations. Viyash is now equipped with the digital infrastructure and strategic clarity needed to pursue long-term decarbonisation and maintain a competitive edge in international markets.